| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-28 | FY 2024
FILED 2024-12-29 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.70B | $4.14B | $5.00B |
| YoY Revenue Growth % | +13.7% | -17.3% | — |
| Gross Profit | $3.41B | $2.96B | — |
| Gross Margin % | 72.4% | 71.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $11.1M | $690.0M | -$1.54B |
| Operating Margin % | 0.2% | 16.7% | -30.8% |
| Net Income (GAAP) | -$322.4M | $385.6M | -$1.49B |
| EBITDA (Normalized) | $61.7M | $759.8M | -$1.36B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $893.2M | $847.4M | $725.6M |
| Capital Expenditures (CapEx) | $63.3M | $87.2M | $225.1M |
| Free Cash Flow (FCF) | $829.9M | $760.2M | $500.5M |
| FCF Margin % | 17.7% | 18.4% | 10.0% |
| Return on Invested Capital (ROIC %) | 0.3% | 14.1% | -21.7% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $2.77B | $3.38B | $2.17B |
| Total Stockholders' Equity | $565.5M | $1.19B | $4.45B |